In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65

To replace mechanical ventilation (MV), which represents the cornerstone therapy in severe COVID-19 cases, high-flow nasal oxygen (HFNO) therapy has recently emerged as a less-invasive therapeutic possibility for those patients. Respecting the risk of MV delay as a result of HFNO use, we aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kljakovic Gaspic, Toni, Pavicic Ivelja, Mirela, Kumric, Marko, Matetic, Andrija, Delic, Nikola, Vrkic, Ivana, Bozic, Josko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399648/
https://www.ncbi.nlm.nih.gov/pubmed/34440479
http://dx.doi.org/10.3390/life11080735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399648/
https://www.ncbi.nlm.nih.gov/pubmed/34440479
http://dx.doi.org/10.3390/life11080735

Ejemplares similares